These processes facilitate the synthesis of cellular membranes during cell proliferation suggesting that HER2-overexpressing breast cancer cells alter their metabolism to improve triglyceride synthesis and lipid uptake/incorporation for cell proliferation [1–3]. This evidence concerns the gene ERBB2 and breast carcinoma.